Guanfacine Extended-Release: In Attention Deficit Hyperactivity Disorder

Author： Muir Victoria J.   Perry Caroline M.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.70, Iss.13, 2010-09, pp. : 1693-1702

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Guanfacine extended-release for attention-deficit/hyperactivity disorder (ADHD)

By Sallee Floyd R   Eaton Katherine  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 15, 2010-10 ,pp. : 2549-2556

Informa Healthcare

Access to resources Recommend Favorite

Clonidine Extended-Release: In Attention-Deficit Hyperactivity Disorder

By Croxtall Jamie D.  

Pediatric Drugs, Vol. 13, Iss. 5, 2011-10 ,pp. : 329-336

Adis International

Access to resources Recommend Favorite

Clonidine Extended-Release In Attention-Deficit Hyperactivity Disorder†: Profile Report

By Croxtall Jamie D.  

CNS Drugs, Vol. 26, Iss. 3, 2012-03 ,pp. : 277-279

Adis International

Access to resources Recommend Favorite

Dexmethylphenidate Extended Release: In Attention-Deficit Hyperactivity Disorder

By Robinson Dean M.   Keating Gillian M.  

Drugs, Vol. 66, Iss. 5, 2006-01 ,pp. : 661-668

Adis International

Access to resources Recommend Favorite

Effects of Guanfacine Extended Release on Oppositional Symptoms in Children Aged 6-12 Years with Attention-Deficit Hyperactivity Disorder and Oppositional Symptoms: A Randomized, Double-Blind, Placebo-Controlled Trial

By Connor Daniel F.  

CNS Drugs, Vol. 24, Iss. 9, 2010-09 ,pp. : 755-768

Adis International

Access to resources Recommend Favorite